Clinical Trial Update: Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025 [Phase 3]

View source ↗

Summary

This clinical trial update reports the termination of a Phase 3 study evaluating two doses of EVP-6124 in subjects with Alzheimer's disease and dementia, focusi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• EVP-6124

Snippet

Sponsor: FORUM Pharmaceuticals Inc | Conditions: Alzheimer's Disease, Dementia | Phase 3 | Status: TERMINATED